FORMULATION AND IN VITRO–IN VIVO PHARMACOKINETIC EVALUATION OF CARDIOVASCULAR DRUG-LOADED PULSATILE DRUG DELIVERY SYSTEMS

KUMAR BABU PASUPULETI; VENKATACHALAM A.; BHASKAR REDDY KESAVAN

doi:10.22159/ijap.2021v13i6.42607

Authors

KUMAR BABU PASUPULETI Department of Pharmaceutics, Pacific Academy of Higher Education and Research University, Udaipur, India
VENKATACHALAM A. Department of Pharmaceutics, Pacific Academy of Higher Education and Research University, Udaipur, India
BHASKAR REDDY KESAVAN Department of Pharmaceutics, Centre of Pharmaceutical Nanotechnology, Sri Venkateswara College of Pharmacy, RVS Nagar, Chittoor, India

DOI:

https://doi.org/10.22159/ijap.2021v13i6.42607

Keywords:

Liquid solid composite, Compresses tablet, Optimization, Disintegration time, Wetting time

Abstract

Objective: This study is to formulate Nebivolol into a Pulsatile liquid, solid composite compression coated tablet, which will delay the release of the drug in early morning hypertension conditions.

Methods: The liquid, solid composite tablet was formulated and compressed with the ethylcellulose coating polymer. The percent in vitro drug release of the liquid solid composite compressed tablet was tested. Based on disintegration time and wetting time, the LCS2, LCS3, LSC6, LCS7 and LCS12 formulations were found to be the optimized solid-liquid compacts fast-dissolving core tablet formulations, which may be excellent candidates for further coating with polymer to transfer into press coated pulsatile tablet formulations. Coating the core tablet with varying ethyl cellulose concentrations resulted in five different formulations of the pulsatile press-coated tablet (CT1, CT2, CT3, CT4, CT5). In vitro drug release, in vitro release, kinetic studies, in vivo pharmacokinetic and stability tests were all performed for the prepared pulsatile press coated tablet.

Results: CT3 tablets are coated with ethyl cellulose polymer, which shows maximum controlled drug release from the core tablet i.e. 96.34±1.2% at 8^th h. It shows there was an efficient delay in drug release form core tablet i.e. up to 3 h, followed by the maximum amount of drug release of 96.34±2.4 at 8h. Which shows the core drug will be more efficiently protected from the gastric acid environment 1.2 pH, duodenal environment 4.0 pH and release drug only in the small intestine.

Conclusion: According to the findings, CT3 Pulsatile press-coated tablet increased the bioavailability of Nebivolol by 3.11 percent.

Downloads

Download data is not yet available.

References

Patel BB, Shah CN. Recent research on liquid, solid technology for solubility enhancement-a review. Int J Adv Pharm. 2016;5:1-7.

Sowmya P. Venkatesh Dp, S Nayek. Pulsatile drug delivery system: a formulation approach for the treatment of diseases. Int J Curr Pharm Res. 2020;12:16-21.

Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Controlled Release. 2001;73(1):103-10. doi: 10.1016/S0168-3659(01)00291-7.

Kawabata Yohei, Wada Koichi, Nakatani Manabu, Yamada Shizuo, Onoue Satomi. Formulation design for poorly water-soluble drugs based on Biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420(1):1-10. doi: 10.1016/j.ijpharm.2011.08.032, PMID 21884771.

Shinde AKJ, Patil Nidhi S, Jadhav Trupti S, More Harinath N. Design and development of floating pulsatile drug delivery of losartan potassium. Int J App Pharm. 2020;12:218-27. doi: 10.22159/ijap.2020v12i4.37607.

Mohamad Ahmad, Dashevsky Andrei. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD. Eur J Pharm Biopharm. 2006;64(2):173-9. doi: 10.1016/j.ejpb.2006.04.006, PMID 16814532.

Khan Zaheeda, Pillay Viness, Choonara Yahya E, du Toit Lisa C. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol. 2009;14(6):602-12. doi: 10.3109/10837450902922736, PMID 19883249.

Vishal V, Bilaskar Indrajeet S. Patil, Omkar A patil, Girishchandra R Mandke, Shrinivas K Mohite. Design, development and optimization of pulsatile drug delivery of an antihypertensive drug. Int Res J Pharm Biosci 2018;4(6):12-9.

Anil A, Thomas L, Sudheer P. Liquisolid compacts: an innovative approach for dissolution enhancement. Int J Pharm Pharm Sci. 2018;10(6):1-7. doi: 10.22159/ijpps.2018v10i6.25500.

Dalvi PB, Ingale PR. Liquisolid technique: an approach for enhancement of solubility. World J PharmSci. 2014;3:434-46.

Spireas S, Bolton M. Liquisolid systems and methods of preparing same, U.S Patent 5 1999;968:550.

Javadzadeh Yousef, Jafari-Navimipour Baharak, Nokhodchi Ali. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 2007;341(1-2):26-34. doi: 10.1016/j.ijpharm.2007.03.034, PMID 17498898.

Karmarkar AB, Gonjari ID, Hosman AH, Dhabal PN, Bhis SB. Liquisolid tablets: a novel approach for drug delivery. Int J Health Res. 2009;2(1):45-50. doi: 10.4314/ijhr.v2i1.55386.

Bauskar Mohit D, Nandedkar SY, Wagh Rajendra D. Formulation design and optimization of pulsatile release tablet of acebrophlline with swelling and erodible layers for treatment of nocturnal bronchial asthma. Int J Pharm Sci Res. 2011;2:3100-8.

Chandramouli Golla, Agaiah Gouud B, Mallikarjun B, Srikanth L. Design and Evaluation of Press coated pulsatile delivery of doxofylline tablets. Acta Sci Pharm Sci. 2018;2:58-62.

Haritha B. A review on an evaluation of tablets. J Formulation Sci Bioavailability. 2017;1:1-5.

Uddin MS, Mamun AA, Tasnu T, Asaduzzaman M. In-process and finished products quality control tests for pharmaceutical tablets according to pharmacopoeias. J Chem Pharm Res. 2015;7:180-5.

Yadav AV, Shete AS, Dabke AP. Formulation and evaluation of orodispersible Liquisolid Compacts of aceclofenac. Ind J Pharm Educ Res. 2010;4:227-35.

Fahmy Rania H, Kassem Mohammed A. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;69(3):993-1003. doi: 10.1016/j.ejpb.2008.02.017, PMID 18396390.

Sanjayamitra PVSS, Ganesh GNK. Dissolution and solubility enhancement strategies: current and novel prospectives. Crit Rev. 2018;5:1-10.

Maddiboyina Balaji, Nakkala Ramya Krishna. Kokkilagada Vinod kumar. Preparation and evaluation of esmeprazole enetriccoated tablets. Int J Pharm Pharm Sci. 2020;18:16-30.

Patil Basawaraj S, Motagi Abhishek M, Kulkarni Upendra, Hariprasanna RC, Shivan, Patil A. Development and evaluation of time controlled pulsatile release lisinopril tablets. J Biol Sci Res. 2012;2:30-5.

Singh Bhupendra, Singh Geetanjali, Vyas Manish, Verma Surajapal, Thakur Sourav. Optimized chronomodulated dual release bilayer tablets of fexofenadine and montelukast: quality by design, development, and in vitro evaluation. Future J Pharm Sci. 2019;5:1-20.

Chenna R, Reddy YP. Formulation and in vivo evaluation of chronomodulated drug delivery of nimodipine. IJPSDR 2019;11(6). doi: 10.25004/IJPSDR.2019.110607.

Sangram M, Patil Rajesh V, Mishra Satish V, Shirolkar. Development and evaluation of sustained released simvastatin pellets. Res J Pharm Dev. 2017;10:2467-73.

Rajab NA. Preparation and in vitro evaluation of lacidipine oral liquid solid tablet as an approach of solubility and dissolution rate enhancement. Int J Appl Pharm. 2018;10(1):145-53. doi: 10.22159/ijap.2018v10i1.22313.

Chronopharmacokinetics Lemmer B. Implications for drug treatment. J Pharm Pharmacol. 1999;51:887-90.

Löbenberg Raimar, Kim Jae Seung, Amidon Gordon L. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs. Eur J Pharm Biopharm. 2005;60(1):17-23. doi: 10.1016/j.ejpb.2004.11.010, PMID 15848051.

Qureshi Mohd Javed, Ali Javed, Baboota Sanjula, Ahuja Alka, Mallikarjun C. Pharmacokinetic study of a capsule-based chronomodulated drug delivery system of salbutamol sulphate in rabbits. Trop J Pharm Res. 2014;13(1):17-22. doi: 10.4314/tjpr.v13i1.3.

Chauhan SK, Tyagi A, Singh B, Agarwal S. Accelerated stability studies of a polyherbal preparation (eazmov(r)) capsule. Anc Sci Life. 1999;18(3-4):210-7. PMID 22556893.

Shrivastava Agnivesh R, Ursekar Bhalchandra, Kapadia Chhanda J. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets. Curr Drug Delivery. 2009;6(1):28-37. doi: 10.2174/ 156720109787048258, PMID 19418953.